Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700018793

Trial Profile

Clinical Trials Insight: 700018793

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2006

At a glance

  • Drugs Sapacitabine (Primary)
  • Indications Lymphoma; Solid tumours
  • Focus Adverse reactions
  • Sponsors Cyclacel Pharmaceuticals
  • Most Recent Events

    • 22 Nov 2006 18th EORTC-NCI-AACR Symposium
    • 21 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top